Cargando…
Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression
BACKGROUND: Secreted protein acidic and rich in cysteine (SPARC) is a multi-faceted protein-modulating cell–cell and cell–matrix interactions. In cancer, SPARC can be not only associated with a highly aggressive phenotype, but also acts as a tumour suppressor. The aim of this study was to characteri...
Autores principales: | Chen, G, Tian, X, Liu, Z, Zhou, S, Schmidt, B, Henne-Bruns, D, Bachem, M, Kornmann, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813737/ https://www.ncbi.nlm.nih.gov/pubmed/19920824 http://dx.doi.org/10.1038/sj.bjc.6605440 |
Ejemplares similares
-
Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions
por: Prokopchuk, O, et al.
Publicado: (2005) -
Aberrant methylation of SPARC in human lung cancers
por: Suzuki, M, et al.
Publicado: (2005) -
FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients
por: Streit, S, et al.
Publicado: (2006) -
Pancreatic stellate cells promote hapto-migration of cancer cells through collagen I-mediated signalling pathway
por: Lu, J, et al.
Publicado: (2014) -
FGFR2 gene amplification and clinicopathological features in gastric cancer
por: Matsumoto, K, et al.
Publicado: (2012)